D
Droplette
Needle-free and hand-held device that delivers large molecules deep through skin
About Droplette
Droplette, a Boston-based company founded in 2017, operates at the intersection of medical science and consumer skincare. The company was established by two MIT-trained chemical engineers, Madhavi Gavini and Rathi Srinivas. Their journey began after attending a medical conference where they learned about epidermolysis bullosa (EB), a rare and painful genetic skin disease that primarily affects children. Motivated to find a painless method to deliver medication through the skin, they began experimenting with fluid physics, initially working with components purchased from eBay at Gavini's kitchen table. This research led to a breakthrough in transdermal delivery, which garnered early grant funding from NASA and the National Institutes of Health (NIH).
The core of Droplette's business is a smart device that transforms proprietary skincare serums into a high-velocity micro-mist. This technology, leveraging principles like fluid dynamics and the piezoelectric effect, creates droplets thousands of times smaller than traditional misters, allowing them to penetrate the skin's barrier up to 20 cell layers deep. This process enhances the efficacy of active ingredients, which often struggle to be absorbed when applied topically. The company's business model revolves around selling the handheld device and a subscription-based service for its single-use capsules containing various formulations. These capsules are formulated with dermatologist-recommended ingredients such as collagen, retinol, and glycolic acid to address concerns like hydration, fine lines, and blemishes.
The company's target market is the at-home consumer seeking clinical-grade skincare results without invasive procedures. Revenue is generated from the initial sale of the device and recurring monthly subscriptions for the serum capsules. Droplette has successfully raised significant capital to fuel its growth, including a Series B round that brought its total funding to over $39.5 million. Key investors include Spark Capital, Victress Capital, and Bolt. The company launched its second-generation device, Droplette 2, in 2023, featuring hardware and software upgrades, and a more integrated mobile app that allows users to connect with licensed estheticians for personalized guidance.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Boston, United States
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 58.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Risk Management, Oncology, Dermatology, Non-Invasive medical devices and treatments, Disease, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Dec 2021 | $15M | $62M | Spark Capital · Amplifyher Ventures · Victress Capital · Bolt Innovation Group | ↗ |
| SEEDEquity / VC | Mar 2019 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Droplette is 0 monthly website visits. Droplette's team declined 21.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
MassChallenge
Series A4 investors entered at this stage
Spark Capital
Victress Capital
Amplifyher Ventures
Bolt Innovation Group
Other known investors4 additional known investors
Alumni Ventures
Daniel Vannoni
K5 Global
Towerview Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Droplette on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Droplette’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







